|
|
Other links at Articles > Cardiology |
| 1. |
BRIEF-PCI: Infusion of Eptifibatide Can Be Shortened
|
|
|
A shortened, two-hour infusion of the GP IIb/IIIa inhibitor eptifibatide following nonemergency PCI is just as effective as the standard 18-hour infusion of the drug and is probably safer, according to a new study. Heartwire
|
| 2. |
FDA Approvals: Avalide and Ixempra
|
|
|
The FDA has approved a new indication for irbesartan/hydrochlorothiazide tablets (Avalide) and ixabepilone injection (Ixempra). Medscape Medical News
|
|
|